CellSeedCellSeed Inc.7776東証グロース精密機器FY ending Dec 2025, non-consolidated, J-GAAP

CellSeed FY ending Dec 2023 results

About 96% of CellSeed's sales come from Laboratory consumables and equipment, with Cell-Sheet regenerative medicine making up much of the rest.

It lost about ¥367 for every ¥100 of sales at the operating level.

Revenue changed +50.4% from the prior year.

What changed from last year

FY ending Dec 2022 → FY ending Dec 2023

Revenue
+50.4%¥126.4M → ¥190.1M
Gross profit
+75.6%¥61M → ¥107.2M
Operating income
Loss-¥743.2M → -¥697.8M
Operating cash flow
Loss-¥718M → -¥779.4M
Free cash flow
Loss-¥733.6M → -¥801.1M

Where the money goes

FY ending Dec 2022 → FY ending Dec 2023

Where ¥100 of sales goes

For every ¥100 CellSeed sells, how much goes where, and how much is kept.

FY ending Dec 2023
Cost of sales
¥44
SG&A
¥423
Operating loss
¥367
Net loss
¥445

Annual margin trends

Gross margin56.4%
FY ending Dec 2019: 78.5%78.5%FY ending Dec 2020: 69.3%69.3%FY ending Dec 2021: 52.0%52.0%FY ending Dec 2021: 52.0%52.0%FY ending Dec 2022: 48.3%48.3%FY ending Dec 2023: 56.4%56.4%FY19FY20FY21FY21FY22FY23
Operating margin-367.0%
FY ending Dec 2019: -283.1%-283.1%FY ending Dec 2020: -360.7%-360.7%FY ending Dec 2021: -534.8%-534.8%FY ending Dec 2021: -534.5%-534.5%FY ending Dec 2022: -587.9%-587.9%FY ending Dec 2023: -367.0%-367.0%FY19FY20FY21FY21FY22FY23
Net margin-445.2%
FY ending Dec 2019: -283.7%-283.7%FY ending Dec 2020: -393.0%-393.0%FY ending Dec 2021: -565.7%-565.7%FY ending Dec 2021: -565.7%-565.7%FY ending Dec 2022: -600.9%-600.9%FY ending Dec 2023: -445.2%-445.2%FY19FY20FY21FY21FY22FY23

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Dec 2023

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第25期(2025/01/01-2025/12/31)

    ID S100XUKD2026-03-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第24期(2024/01/01-2024/12/31)

    ID S100VGWL2025-03-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第23期(2023/01/01-2023/12/31)

    ID S100T4XQ2024-03-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第22期(2022/01/01-2022/12/31)

    ID S100QIL12023-03-31Open
  • EDINET (FSA Japan)

    有価証券報告書-第21期(令和3年1月1日-令和3年12月31日)

    ID S100NR3A2022-03-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第20期(令和2年1月1日-令和2年12月31日)

    ID S100L1WE2021-03-29Open

Extracted from XBRL: 41 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.